Avid Radiopharmaceuticals and Lighthouse Capital Partners
Posted: 20 Oct 2009
Date Written: October 5, 2009
Abstract
In fall 2008, a venture lender must decide whether to make a loan to Avid, a small but promising venture-backed life sciences firm. In reviewing her proposal, Cristy Barnes considers the company's characteristics and how they differ from a typical investment. At the same time, the CEO and the venture capitalist are exploring the true costs and benefits of taking the loan, particularly in the uncertain economic climate of the time.
Suggested Citation: Suggested Citation
Rhodes-Kropf, Matthew and Leamon, Ann, Avid Radiopharmaceuticals and Lighthouse Capital Partners (October 5, 2009). HBS Case No. 810-054, Harvard Business School Entrepreneurial Management, Available at SSRN: https://ssrn.com/abstract=1491075
Matthew Rhodes-Kropf (Contact Author)
Harvard Business School - Entrepreneurial Management Unit ( email )
Soldiers Field Road
Rock Center 312
Boston, MA 02163
United States
Feedback
Feedback to SSRN
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.